ERS International Congress, Madrid 2019

Browse by day:
Saturday, 28.09.2019
Sunday, 29.09.2019
Monday, 30.09.2019
Tuesday, 01.10.2019
Wednesday, 02.10.2019

 

View the presentations you missed during Congress!

More than 1,000 webcasts and slide presentations, 1,900 e-posters and 4,200 abstracts from the International Congress in Madrid and are now available.

 

Citations should be made in the following way: Authors. Title. Eur Respir J 2019; 54: Suppl. 63, abstract number.


New towards old therapies in airway diseases

Oral Presentation
Chairs: D. Halpin (Devon, United Kingdom), D. Singh (Manchester, United Kingdom)
Late Breaking Abstract - Anti-IL-4 and anti-IL-13 dual vaccination using Kinoid technology prevents development of allergic asthma in mice
E. Conde Garcia (Paris, France), R. Bertrand (Paris, France), B. Balbino (Paris, France), J. Bonnefoy (Paris, France), J. Stackowicz (Paris, France), N. Caillot (Paris, France), F. Colaone (Paris, France), S. Hamdi (Paris, France), P. Bruhns (Paris, France), V. Serra (Paris, France), G. Grouard-Vogel (Paris, France), L. Reber (Paris, France)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Late Breaking Abstract - Spatial pharmacokinetics of inhaled drugs in human lung – evaluation of regional lung targeting by direct sampling of epithelial lining fluid
M. Sadiq (Gothenburg, Sweden), O. Holz (Hannover, Germany), B. Ellinghusen (Hannover, Germany), C. Faulenbach (Hannover, Germany), M. Müller (Hannover, Germany), P. Badorrek (Hannover, Germany), U. Eriksson (Gothenburg, Sweden), M. Fridén (Gothenburg, Sweden), S. Stomilovic (Gothenburg, Sweden), A. Lundqvist (Gothenburg, Sweden), J. Hohlfeld (Hannover, Germany)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study
T. Harrison (Nottingham, United Kingdom), G. Canonica (Milan, Italy), K. Gemzoe (Uxbridge, United Kingdom), A. Maxwell (Stevenage, United Kingdom), S. Yang (Collegeville, United States of America), S. Joksaite (Uxbridge , United Kingdom), R. O’Reilly (Stevenage, United Kingdom), M. Van Dyke (Upper Providence, United States of America), F. Albers (Research Triangle Park, United States of America), N. Kwon (Brentford, United States of America)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - SABA overuse and risk of mortality in a nationwide Swedish asthma cohort (HERA)
C. Janson (Lund, Sweden), B. Nwaru (Gothenburg, Sweden), L. Hasvold (Södertälje, Sweden), F. Wiklund (Uppsala, Sweden), G. Telg (Södertälje, Sweden), M. Ekström (Lund, Sweden)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - Dose responses for topical efficacy and systemic activity, dose equivalence and relative therapeutic index for fluticasone furoate (FF), fluticasone propionate (FP) and budesonide (BUD) in asthmatic subjects.
P. Daley-Yates (Uxbridge, United Kingdom), N. Brealey (Uxbridge, United Kingdom), B. Kumar (Bangalore, India), S. Thomas (Bangalore, India), D. Austin (Uxbridge, United Kingdom), S. Shabbir (Stevenage, United Kingdom), T. Harrison (Nottingham, United Kingdom), D. Singh (Manchester, United Kingdom), N. Barnes (Brentford, United Kingdom)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - Overprescription of short-acting beta2-agonists in asthma management? Pharmacy reports from 91,673 patients in Poland
M. Kupczyk (Lodz, Poland), W. Barg (Wroclaw, Poland), G. Bochenek (Krakow, Poland), G. Brozek (Katowice, Poland), D. Brzostek (Warsaw, Poland), P. Dabrowiecki (Warsaw, Poland), A. Dabrowski (Warsaw, Poland), R. Dobek (Warsaw, Poland), R. Gawlik (Katowice, Poland), A. Kucharczyk (Warsaw, Poland), I. Kuprys-Lipinska (Lodz, Poland), A. Mastalerz-Migas (Wroclaw, Poland), E. Zagrajek (Warsaw, Poland), M. Kowalski (Lodz, Poland)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - Influence of salbutamol use on symptomatic outcomes with maintenance bronchodilators: a pre-specified analysis of the EMAX trial
F. Maltais (Québec, QC, Canada), I. Naya (Brentford, Middlesex, United Kingdom), E. Kerwin (Medford, OR, United States of America), L. Bjermer (Lund, Sweden), I. Boucot (Brentford, Middlesex, United Kingdom), P. Jones (Brentford, Middlesex, United Kingdom), L. Tombs (Uxbridge, Middlesex, United Kingdom), D. Lipson (Collegeville, PA, United States of America), C. Compton (Brentford, Middlesex, United Kingdom), C. Vogelmeier (Marburg, Germany)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation